Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. "2025 was ...
The probe began after STAT and others reported on UnitedHealth's strategies to boost profits in Medicare Advantage.
Fourth quarter revenue expected to be $15.9 million to $16.1 million, representing growth of 4% to 5%Full year revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback